Risk-benefit/cost-benefit : improving government regulation of approval of new drugs

著者

• Ricardo-Campbell, Rita

書誌事項

Risk-benefit/cost-benefit : improving government regulation of approval of new drugs

remarks by Rita Ricardo-Campbell, presented at the World Congress on Health and Economics [i.e. World Congress on Health Economics] Leyden University, Leyden, The Netherlands, September 9, 1980

Hoover Institution, Stanford University, 1980

注記

Includes bibliographical references

詳細情報

• NII書誌ID(NCID): BA06868051
• LCCN: 81166055
• 出版国コード: us
• タイトル言語コード: eng
• 本文言語コード: eng
• 出版地: [Sanford, Calif.]
• ページ数/冊数: 21 p.
• 大きさ: 23 cm
• 分類:
  • LCC : RA401.A3
  • DC19 : 363.1/946/0973
• 件名:
  • LCSH : Pharmaceutical policy -- United States
  • LCSH : Drugs -- Testing -- Government policy -- United States
  • LCSH : Drugs -- Cost effectiveness
  • LCSH : Drugs -- United States -- Cost effectiveness